cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $743,711. The enterprise value is $398,863.
Important Dates
The next confirmed earnings date is Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 782,854 shares outstanding. The number of shares has increased by 94.06% in one year.
| Current Share Class | 782,854 |
| Shares Outstanding | 782,854 |
| Shares Change (YoY) | +94.06% |
| Shares Change (QoQ) | -30.66% |
| Owned by Insiders (%) | 16.91% |
| Owned by Institutions (%) | 3.94% |
| Float | 592,261 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| Forward PS | 0.04 |
| PB Ratio | 0.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of 0.91.
| Current Ratio | 0.69 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | n/a |
| Interest Coverage | -80.30 |
Financial Efficiency
Return on equity (ROE) is -60.98% and return on invested capital (ROIC) is -21.14%.
| Return on Equity (ROE) | -60.98% |
| Return on Assets (ROA) | -10.96% |
| Return on Invested Capital (ROIC) | -21.14% |
| Return on Capital Employed (ROCE) | -98.43% |
| Revenue Per Employee | $457,625 |
| Profits Per Employee | -$159,346 |
| Employee Count | 42 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.43% in the last 52 weeks. The beta is 2.77, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.77 |
| 52-Week Price Change | -82.43% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 28.75 |
| Average Volume (20 Days) | 113,863 |
Short Selling Information
The latest short interest is 102,825, so 13.13% of the outstanding shares have been sold short.
| Short Interest | 102,825 |
| Short Previous Month | 55,488 |
| Short % of Shares Out | 13.13% |
| Short % of Float | 17.36% |
| Short Ratio (days to cover) | 0.70 |
Income Statement
In the last 12 months, cbdMD had revenue of $19.22 million and -$6.69 million in losses. Loss per share was -$11.39.
| Revenue | 19.22M |
| Gross Profit | 11.84M |
| Operating Income | -2.34M |
| Pretax Income | -21.65M |
| Net Income | -6.69M |
| EBITDA | -1.17M |
| EBIT | -2.34M |
| Loss Per Share | -$11.39 |
Full Income StatementBalance Sheet
The company has $1.97 million in cash and $1.63 million in debt, giving a net cash position of $344,848 or $0.44 per share.
| Cash & Cash Equivalents | 1.97M |
| Total Debt | 1.63M |
| Net Cash | 344,848 |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 1.78M |
| Book Value Per Share | 2.56 |
| Working Capital | -2.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$564,861 and capital expenditures -$169,767, giving a free cash flow of -$734,628.
| Operating Cash Flow | -564,861 |
| Capital Expenditures | -169,767 |
| Free Cash Flow | -734,628 |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
Gross margin is 61.59%, with operating and profit margins of -12.15% and -13.99%.
| Gross Margin | 61.59% |
| Operating Margin | -12.15% |
| Pretax Margin | -13.99% |
| Profit Margin | -13.99% |
| EBITDA Margin | -6.10% |
| EBIT Margin | -12.15% |
| FCF Margin | n/a |